Invesaro

Stocks KARX Financial statements

Financial statements

Karbon-X Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Karbon-X Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue00000.010.413.1655.9
Cost of revenue000.362.3655
Gross profit00.010.060.80.86
General and administrative000.01
Operating expenses0.020.040.241.991.577.4511.9
Operating income-0.24-1.98-1.51-6.65-11.1
Interest expense00.040.343.32
Other non-operating income-0.04-0.030-0.0100.01-0.05
Pre-tax income-0.02-0.04-0.03-0.24-1.99-2.74-7.05-13.6
Income tax00000
Net income-0.02-0.04-0.03-0.23-1.99-2.74-7.05-13.6
EBITDA-0.24-1.98-1.51-6.64-10.9
EPS, basic0.000.000.00-0.08-0.16
EPS, diluted0.000.000.00-0.04-0.08-0.16
Shares, basic (weighted)2001976586.7
Shares, diluted (weighted)200197656577.283.686.7

Balance sheet

FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents0000.480.212.680.71.16
Short-term investments0
Receivables0.010.050.1200.63
Inventory0.080.320.10.65
Other current assets00.0200.06000.16
Total current assets000.020.490.313.115.796.06
Property, plant and equipment00.010.010.010.01
Lease right-of-use assets00.070.320.50.42
Intangible assets00.64
Other non-current assets0.011.55
Total assets0.672.523.976.789.62
Accounts payable00.0100.030.070.131.092.26
Accrued liabilities0.020.020.15
Deferred revenue03.863.79
Short-term debt00.10.040
Total current liabilities0.010.040.090.030.190.847.6910.1
Long-term debt004.88
Lease liabilities0.080.060.30.460.37
Other non-current liabilities00.46
Total liabilities0.01-0.030.020.030.251.148.1515.6
Total debt004.88
Paid-in capital-0.2-0.05-0.050.792.647.6810.619.3
Retained earnings-0.02-0.05-0.08-0.2-2.19-4.94-12-25.6
Other comprehensive income-0.01-00.01-0.020.22
Shareholders' equity-0.010.0300.642.272.83-1.37-5.98
Total equity-0.010.0300.642.272.83-1.37-5.98
Total liabilities and equity000.020.672.523.976.789.62
Shares outstanding20064.964.968.373.582.28294.9

Cash flow statement

FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-0.02-0.04-0.03-0.24-1.99-2.74-7.05-13.6
Depreciation and amortization00000.2
Stock-based compensation00.6300.631.26
Change in receivables0.010-0.110.12-0.63
Change in inventory0-0.08-0.240.22-0.55
Change in payables00-00.030.040.030.331.16
Cash from operations-0-0.01-0-0.18-1.49-1.1-6.5-7.86
Capital expenditures-0-0.010-0-0
Cash from investing000-0.18-0.75-0.8-0-2.43
Debt issued00.104.79
Stock issued0.0101.864.321.710.24
Share buybacks-00
Cash from financing00.0200.861.964.364.5610.5
Exchange rate effect-0.01-0.010.01-0.030.24
Net change in cash-00-00.48-0.272.47-1.970.45
Free cash flow-0.19-1.49-1.1-6.5-7.87
Interest paid00000000.5
Income taxes paid00000000

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $0.15 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin1.5%Gross profit / revenue.
Operating margin-19.8%Operating income / revenue.
EBITDA margin-19.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-24.3%Pre-tax income / revenue.
Net margin-24.3%Net income / revenue.
FCF margin-14.1%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-14.1%Cash from operations / revenue.
Return on assets (ROA)-165.8%Net income / average total assets.
Stock-based pay / revenue2.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.0%Capital expenditures / revenue.
D&A / revenue0.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y1,666.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1,684.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y7.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y360.4%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y41.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y56.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y3.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y6.0%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.60xCurrent assets / current liabilities.
Quick ratio0.18x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.11x(Cash + short-term investments) / current liabilities.
Debt / assets50.7%Total debt / total assets.
Liabilities / assets162.2%Total liabilities / total assets.
Net debt$3.7MTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-3.33xOperating income / interest expense.
Working capital-$4.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets6.7%(Goodwill + intangible assets) / total assets.
Tangible book value-$6.6MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover6.81xRevenue / average total assets.
Fixed asset turnover7,903xRevenue / average property, plant and equipment.
Inventory turnover147xCost of revenue / average inventory.
Days inventory2 days365 x average inventory / cost of revenue.
Receivables turnover176xRevenue / average receivables.
Days sales outstanding2 days365 x average receivables / revenue.
Days payables11 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-7 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.16Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$0.16Net income per basic share, as reported (split-adjusted).
Revenue per share$0.64Revenue / diluted weighted shares.
FCF per share-$0.09Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.09Cash from operations / diluted weighted shares.
Book value per share-$0.06Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.07Tangible book value / shares outstanding.
Cash per share$0.01(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$14.8MShare price x shares outstanding.
Enterprise value$18.6MMarket cap + total debt - cash - short-term investments.
P/S0.27xMarket cap / revenue.
EV/Sales0.33xEnterprise value / revenue.
FCF yield-53.0%Free cash flow / market cap.
Earnings yield-91.5%Net income / market cap (the inverse of P/E).
What was Karbon-X Corp.'s revenue in fiscal 2026?

Karbon-X Corp. reported revenue of $55.9M for fiscal 2026, 1,665.6% higher than the year before.

Was Karbon-X Corp. profitable in fiscal 2026?

No. It reported a net loss of $13.6M.

How much free cash flow did Karbon-X Corp. generate in fiscal 2026?

Cash from operations of $7.9M minus capital expenditures of $4.3K left free cash flow of -$7.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Karbon-X Corp.